Article Information
History
- March 9, 2020.
Article Versions
- Version 1 (February 27, 2020 - 18:48).
- Version 2 (February 28, 2020 - 18:00).
- You are currently viewing Version 3 of this article (March 9, 2020 - 01:54).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- CV Hersta,
- S Burkholza,
- J Sidneyi,
- A Settei,
- PE Harrisg,
- S Masseyb,
- T Braselb,
- E Cunha-Netoc,d,e,
- DS Rosad,f,
- WCH Chaoj,
- R Carbacka,
- T Hodgea,
- L Wanga,
- S Ciotlosa,
- P Lloyda and
- R Rubsamena,h,*
- aFlow Pharma, Inc., 3451 Vincent Road, Pleasant Hill, CA 94523
- bUniversity of Texas, Medical Branch, 301 University Blvd, Galveston, TX 77555
- cLaboratory of Clinical Immunology and Allergy-LIM60, University of São Paulo School of Medicine, São Paulo, Brazil
- dInstitute for Investigation in Immunology (iii) INCT, São Paulo, Brazil
- eHeart Institute (Incor), School of Medicine, University of São Paulo, São Paulo, Brazil
- fDepartment of Microbiology, Immunology and Parasitology, Federal University of São Paulo (UNIFESP/EPM), São Paulo, Brazil
- gEndocrinology Division, Department of Medicine, School of Medicine, Columbia University, New York, New York, USA
- hMassachusetts General Hospital, Department of Anesthesia, Critical Care and Pain Medicine, 55 Fruit St, Boston, MA 02114
- iLa Jolla Institute for Allergy and Immunology, 9420 Athena Circle La Jolla, CA 92037
- jUniversity of Macau, E12 Avenida da Universidade, Taipa, Macau, China
- ↵*Corresponding author, Email address: reidrubsamen{at}alum.mit.edu (Rubsamen R)